Chugai Pharmaceutical Co Ltd (CUP) Stock Price & News

Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia

About Chugai Pharmaceutical Co Ltd

CEOOsamu Okuda

Employees5,1 ພັນ

Founded10 ມ.ນ. 1925

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websitechugai-pharm.co.jp

All values in JPY	ທ.ວ. 2025	ມ.ນ. 2026	ມິ.ຖ. 2026	ກ.ຍ. 2026
Revenue	346,30 ຕື້	321,75 ຕື້	341,58 ຕື້	404,74 ຕື້
Cost of goods sold	87,56 ຕື້	92,79 ຕື້	104,22 ຕື້	119,09 ຕື້
Cost of revenue	87,56 ຕື້	92,79 ຕື້	104,22 ຕື້	119,09 ຕື້
Research and development expenses	52,41 ຕື້	41,89 ຕື້	47,76 ຕື້	49,89 ຕື້
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	36,92 ຕື້	28,90 ຕື້	29,04 ຕື້	32,37 ຕື້
Operating expense	89,74 ຕື້	70,19 ຕື້	76,51 ຕື້	82,70 ຕື້
Total operating expenses	177,30 ຕື້	162,98 ຕື້	180,73 ຕື້	201,80 ຕື້
Operating income	169,01 ຕື້	158,76 ຕື້	160,86 ຕື້	202,95 ຕື້
Other non operating income	994,00 ລ້ານ	1,43 ຕື້	3,04 ຕື້	1,74 ຕື້
EBT including unusual items	169,90 ຕື້	160,20 ຕື້	169,02 ຕື້	204,68 ຕື້
EBT excluding unusual items	169,90 ຕື້	160,20 ຕື້	169,02 ຕື້	204,68 ຕື້
Income tax expense	41,50 ຕື້	44,78 ຕື້	52,69 ຕື້	61,13 ຕື້
Effective tax rate	24,42%	27,95%	31,17%	29,87%
Other operating expenses	405,00 ລ້ານ	-596,00 ລ້ານ	-291,00 ລ້ານ	446,00 ລ້ານ
Net income	128,41 ຕື້	115,42 ຕື້	116,33 ຕື້	143,55 ຕື້
Net profit margin	37,08%	35,87%	34,06%	35,47%
Earnings per share	-	-	-	-
Interest and investment income	-	-	5,13 ຕື້	-
Interest expense	-95,00 ລ້ານ	-	-	-
Net interest expenses	-95,00 ລ້ານ	-	5,13 ຕື້	-
Depreciation and amortization charges	-	-	-	-
EBITDA	200,44 ຕື້	159,26 ຕື້	161,56 ຕື້	203,65 ຕື້
Gain or loss from assets sale	4,53 ຕື້	-	-	-

Ask anything